Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

BUY
$70.55 - $111.58 $1.9 Million - $3.01 Million
26,980 Added 6.7%
429,510 $30.3 Million
Q2 2022

Aug 05, 2022

BUY
$50.24 - $80.48 $4.83 Million - $7.74 Million
96,230 Added 31.42%
402,530 $28.6 Million
Q1 2022

May 06, 2022

SELL
$57.98 - $93.5 $2.55 Million - $4.1 Million
-43,900 Reduced 12.54%
306,300 $24.5 Million
Q4 2021

Feb 04, 2022

BUY
$88.02 - $127.79 $18.1 Million - $26.2 Million
205,140 Added 141.42%
350,200 $32 Million
Q3 2021

Nov 08, 2021

SELL
$122.75 - $162.68 $1.98 Million - $2.63 Million
-16,160 Reduced 10.02%
145,060 $18.6 Million
Q2 2021

Aug 09, 2021

SELL
$105.76 - $154.96 $11.9 Million - $17.4 Million
-112,410 Reduced 41.08%
161,220 $24.6 Million
Q1 2021

May 12, 2021

SELL
$78.5 - $126.48 $12.9 Million - $20.9 Million
-164,870 Reduced 37.6%
273,630 $28.8 Million
Q4 2020

Feb 12, 2021

SELL
$55.93 - $82.78 $6.53 Million - $9.67 Million
-116,800 Reduced 21.03%
438,500 $34.7 Million
Q3 2020

Nov 06, 2020

SELL
$45.65 - $61.81 $2.77 Million - $3.75 Million
-60,700 Reduced 9.85%
555,300 $31.4 Million
Q2 2020

Aug 07, 2020

SELL
$29.15 - $61.54 $6.23 Million - $13.1 Million
-213,600 Reduced 25.75%
616,000 $37.9 Million
Q1 2020

May 08, 2020

SELL
$25.01 - $42.4 $1.3 Million - $2.2 Million
-51,900 Reduced 5.89%
829,600 $26.8 Million
Q4 2019

Feb 05, 2020

SELL
$24.55 - $38.13 $2.86 Million - $4.43 Million
-116,300 Reduced 11.66%
881,500 $31 Million
Q3 2019

Nov 05, 2019

SELL
$25.78 - $34.8 $598,096 - $807,359
-23,200 Reduced 2.27%
997,800 $25.7 Million
Q2 2019

Aug 02, 2019

BUY
$23.08 - $37.01 $23.6 Million - $37.8 Million
1,021,000 New
1,021,000 $30 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.15B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Times Square Capital Management, LLC Portfolio

Follow Times Square Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.